Medtronic MiniMed, Inc.

medtronic.com

Total trials

72

Active

5

Phase 3

2

Total enrollment

11,199

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Type 1 Diabetes31
  • Type 1 Diabetes Mellitus14
  • Diabetes Mellitus, Type 16
  • Type 2 Diabetes6
  • Type 2 Diabetes Mellitus6
  • Diabetes5
  • Diabetes Mellitus4
  • Diabetes Mellitus, Type 22

Frequently asked questions about Medtronic MiniMed, Inc.

How many clinical trials does Medtronic MiniMed, Inc. have on ClinicalTrials.gov?
Medtronic MiniMed, Inc. is listed as the lead sponsor on 72 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
How many of Medtronic MiniMed, Inc.'s trials are in Phase 3?
2 of Medtronic MiniMed, Inc.'s trials are in Phase 3.
What therapeutic areas does Medtronic MiniMed, Inc. focus on?
Medtronic MiniMed, Inc.'s most-studied conditions on ClinicalTrials.gov are Type 1 Diabetes, Type 1 Diabetes Mellitus, Diabetes Mellitus, Type 1, Type 2 Diabetes, Type 2 Diabetes Mellitus.